These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18727929)

  • 1. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
    D'Haens GR; Vermeire S; Van Assche G; Noman M; Aerden I; Van Olmen G; Rutgeerts P
    Gastroenterology; 2008 Oct; 135(4):1123-9. PubMed ID: 18727929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial.
    Mañosa M; Cabré E; Bernal I; Esteve M; Garcia-Planella E; Ricart E; Peñalva M; Cortes X; Boix J; Piñol M; Gassull MA; Domènech E
    Inflamm Bowel Dis; 2013 Aug; 19(9):1889-95. PubMed ID: 23689809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
    Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
    J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease management after intestinal resection: a randomised trial.
    De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Gibson PR; Sparrow M; Leong RW; Florin TH; Gearry RB; Radford-Smith G; Macrae FA; Debinski H; Selby W; Kronborg I; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
    Lancet; 2015 Apr; 385(9976):1406-17. PubMed ID: 25542620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine Plus Exclusive Enteral Nutrition Versus Azathioprine Monotherapy for the Prevention of Postoperative Recurrence in Patients with Crohn's Disease: An Open-Label, Single-Centre, Randomized Controlled Trial.
    Duan M; Lu M; Diao Y; Cao L; Wu Q; Liu Y; Gong J; Zhu W; Li Y
    J Crohns Colitis; 2024 Aug; 18(7):1113-1121. PubMed ID: 38253914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
    De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits S; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
    Aliment Pharmacol Ther; 2015 Oct; 42(7):867-79. PubMed ID: 26314275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Crohn's disease surgery: problems of postoperative recurrence].
    Fornaro R; Frascio M; Stabilini C; Sticchi C; Barberis A; Denegri A; Ricci B; Azzinnaro A; Lazzara F; Gianetta E
    Chir Ital; 2008; 60(6):761-81. PubMed ID: 19256268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
    Karoui S; Kallel L; Boubaker J; Filali A
    Tunis Med; 2006 Oct; 84(10):595-8. PubMed ID: 17193847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.
    Cosnes J; Bourrier A; Laharie D; Nahon S; Bouhnik Y; Carbonnel F; Allez M; Dupas JL; Reimund JM; Savoye G; Jouet P; Moreau J; Mary JY; Colombel JF;
    Gastroenterology; 2013 Oct; 145(4):758-65.e2; quiz e14-5. PubMed ID: 23644079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postoperative recurrence of Crohn's disease, and its prevention].
    Lakatos L; Lakatos PL
    Orv Hetil; 2010 May; 151(21):870-7. PubMed ID: 20462847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
    Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
    Treton X; Bouhnik Y; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Cosnes J; Lemann M;
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis.
    Ananthakrishnan AN; Hur C; Juillerat P; Korzenik JR
    Am J Gastroenterol; 2011 Nov; 106(11):2009-17. PubMed ID: 21788991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
    Caprilli R; Taddei G; Viscido A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial.
    Zhu W; Li Y; Gong J; Zuo L; Zhang W; Cao L; Gu L; Guo Z; Li N; Li J
    Dig Liver Dis; 2015 Jan; 47(1):14-9. PubMed ID: 25445405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.